Xenon Pharmaceuticals Inc (XENE)

$10.46 0.00 (0.00%)

16:00 EDT XENE Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 184.22M

PE Ratio -6.97

EPS -1.5

Volume (Avg. Vol.)

Day's Range 10.46 - 10.46

52-Week Range 7.00 - 18.45

Dividend & Yield N/A (N/A)

XENE Stock Predictions, Articles, and Xenon Pharmaceuticals Inc News

From InvestorPlace
From the Web

Xenon Pharmaceuticals Inc (XENE) Plunges on Acne Drug Flop

By William White, InvestorPlace Writer Mar 24, 2017

Xenon Pharmaceuticals (XENE) stock was falling hard on Friday following results from a recent study of its acne drug XEN801.

Benzinga's Top Upgrades, Downgrades For October 2, 2020

From Benzinga Oct 2, 2020

Upgrades According to Evercore ISI Group, the prior rating for Splunk Inc (NASDAQ: SPLK) was changed from In-Line to Outperform. Splunk earned $0.33 in the second quarter,...

Xenon Pharmaceuticals Inc (XENE) Q2 2020 Earnings Call Transcript

From The Motley Fool Aug 7, 2020

XENE earnings call for the period ending June 30, 2020.

Xenon Pharmaceuticals (XENE) Reports Break-Even Earnings for Q2

From Zacks Investment Research Aug 7, 2020

Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of 100.00% and 102.79%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Xenon Pharma EPS beats by $0.24, beats on revenue (NASDAQ:XENE)

From Seeking Alpha Aug 6, 2020

Xenon Pharma (NASDAQ:XENE): Q2 GAAP EPS of $0.00 beats by $0.24.Revenue of $13.38M beats by $6.48M.Press Release

Xenon Pharmaceuticals (XENE) Shares Cross Above 200 DMA

From Market News Video Jul 20, 2020

In trading on Monday, shares of Xenon Pharmaceuticals Inc (XENE) crossed above their 200 day moving average of $12.51, changing hands as high as $12.95 per share. Xenon Pharmaceuticals Inc shares are currently trading up about 4.5% on the day..

Needham Initiates a Buy Rating on Xenon (XENE)

From Analyst Ratings Jul 20, 2020

Xenon (XENE – Research Report) received a Buy rating and a $22.00 price target from Needham analyst Serge Belanger today. The company’s shares closed last Monday at $12.81. According to TipRanks.com, Belanger is a 4-star analyst with an average return of 6.2% and a 47.4% success rate. Belanger covers the Healthcare sector, focusing on stocks

Navellier Ratings

Total Grade

Buy

Breaking news